Skip to content

Retrospective Study to Review Patients at Risk for VTE at Hospital Discharge

VTE Prophylaxis Across the Continuum of Care: High Risk Patients at Hospital Discharge

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00604370
Enrollment
2500
Registered
2008-01-30
Start date
2008-02-29
Completion date
2011-12-31
Last updated
2012-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thromboembolism

Brief summary

An investigator initiated study exploring VTE prophylaxis at the time of hospital discharge.

Detailed description

It appears likely that many patients will remain at risk for VTE at the time of hospital discharge. These risks will go unrecognized, and discharge prophylaxis orders will not be prescribed. To test this hypothesis, we will perform a retrospective review of approximately 2,500 patients at Brigham and Women's Hospital at risk for VTE at the time of hospital discharge to determine what proportion received VTE prophylaxis. We will correlate the implementation of discharge VTE prophylaxis with the occurrence of symptomatic DVT and pulmonary embolism within 90 days of hospital discharge. We will also conduct a substudy of this patient population to determine adherence to VTE prophylaxis among hospitalized patients.

Interventions

None listed

Sponsors

Sanofi
CollaboratorINDUSTRY
Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acutely ill medical and surgical patients with a risk score of 4 or greater without prophylaxis or a risk score of 4 or greater with anticoagulation at hospital discharge.

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frame
Symptomatic PE/DVT within 90 days of hospital discharge.90 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026